TableII.
Comparison between changes in Quality of life before and after the intervention in patients with sickle cell disease
| Total Sample ( N = 69) | |||
|---|---|---|---|
| SF-36 Domains | Baseline | 12 Weeks | P |
| M±SD | M±SD | ||
| Physical functioning 1 | 65.14±22.07 | 88/04±12.52 | <.001 |
| Role limitations-physical 1 | 31.56±36.25 | 76.45±31.47 | <.001 |
| Role limitations-emotional 1 | 36.23±41.12 | 71.50±35.82 | <.001 |
| Social functioning 1 | 56.70±24.68 | 85.33±15.74 | <.001 |
| Pain 1 | 52.75±28/.5 | 76.78±21/03 | <.001 |
| Energy/ fatigue 2 | 47.17±19.35 | 71.75±16.21 | <.001 |
| Emotional well being 2 | 54.90±20.63 | 72.99±16.62 | <.001 |
| General health 2 | 42.97±20.69 | 76.52±16.16 | <.001 |
| Total 1 | 50.94±15.69 | 78.84±11.82 | <.001 |
1
:Paired t test
2
: Wilcoxon test